Oral Esuberaprost Shows No Added Benefit in Pulmonary Arterial Hypertension Trial
A double-blind randomized trial found that adding oral esuberaprost to inhaled treprostinil did not reduce clinical worsening in pulmonary arterial ...
A double-blind randomized trial found that adding oral esuberaprost to inhaled treprostinil did not reduce clinical worsening in pulmonary arterial ...
In the face of increasing global vulnerability to natural disasters, the quest to accurately measure their impact has become paramount ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.